Progress and perspective of organoid technology in cancer-related translational medicine

Biomedicine & Pharmacotherapy - Tập 149 - Trang 112869 - 2022
Yusheng Lin1, Li Jiang1, Qiaojun He1,2,3, Meng Yuan2, Ji Cao1,2,3
1Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
2The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China
3Cancer Center of Zhejiang University, Hangzhou, China

Tài liệu tham khảo